COVID-19 Vaccination Strategy in China: A Case Study

被引:8
作者
Mohamadi, Marjan [1 ]
Lin, Yuling [1 ]
Vulliet, Melissa Vuillet Soit [1 ]
Flahault, Antoine [1 ]
Rozanova, Liudmila [1 ]
Fabre, Guilhem [2 ]
机构
[1] Univ Geneva, Inst Global Hlth, CH-1211 Geneva, Switzerland
[2] Univ Paul Valery Montpellier 3, Dept Chinese, UFR 2, F-34199 Montpellier, France
来源
EPIDEMIOLOGIA | 2021年 / 2卷 / 03期
关键词
COVID-19; SARS-CoV-2; vaccination strategy; China; HEALTH-CARE; MEDIA USE; OUTBREAK; PANDEMICS; HESITANCY; BEHAVIOR; COVERAGE; CRISIS; TRUST;
D O I
10.3390/epidemiologia2030030
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The coronavirus disease 2019 (COVID-19) outbreak in China was first reported to the World Health Organization on 31 December 2019, after the first cases were officially identified around 8 December 2019. However, the case of an infected patient of 55 years old can probably be traced back on 17 November. The spreading has been rapid and heterogeneous. Economic, political and social impacts have not been long overdue. This paper, based on English, French and Chinese research in national and international databases, aims to study the COVID-19 situation in China through the management of the outbreak and the Chinese response to vaccination strategy. The coronavirus disease pandemic is under control in China through non-pharmaceutical interventions, and the mass vaccination program has been launched to further prevent the disease and progressed steadily with 483.34 million doses having been administered across the country by 21 May 2021. China is also acting as an important player in the development and production of SARS-CoV-2 vaccines.
引用
收藏
页码:402 / 425
页数:24
相关论文
共 129 条
[1]  
aetnainternational, Health Care Quality in the Far East: China, Japan, Philippines, South Korea and Taiwan
[2]   Epidemic of COVID-19 in China and associated Psychological Problems [J].
Ahmed, Md Zahir ;
Ahmed, Oli ;
Aibao, Zhou ;
Hanbin, Sang ;
Siyu, Liu ;
Ahmad, Akbaruddin .
ASIAN JOURNAL OF PSYCHIATRY, 2020, 51
[3]   Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults A Randomized Clinical Trial [J].
Al Kaabi, Nawal ;
Zhang, Yuntao ;
Xia, Shengli ;
Yang, Yunkai ;
Al Qahtani, Manaf M. ;
Abdulrazzaq, Najiba ;
Al Nusair, Majed ;
Hassany, Mohamed ;
Jawad, Jaleela S. ;
Abdalla, Jehad ;
Hussein, Salah Eldin ;
Al Mazrouei, Shamma K. ;
Al Karam, Maysoon ;
Li, Xinguo ;
Yang, Xuqin ;
Wang, Wei ;
Lai, Bonan ;
Chen, Wei ;
Huang, Shihe ;
Wang, Qian ;
Yang, Tian ;
Liu, Yang ;
Ma, Rui ;
Hussain, Zaidoon M. ;
Khan, Tehmina ;
Saifuddin Fasihuddin, Mohammed ;
You, Wangyang ;
Xie, Zhiqiang ;
Zhao, Yuxiu ;
Jiang, Zhiwei ;
Zhao, Guoqing ;
Zhang, Yanbo ;
Mahmoud, Sally ;
ElTantawy, Islam ;
Xiao, Peng ;
Koshy, Ashish ;
Zaher, Walid Abbas ;
Wang, Hui ;
Duan, Kai ;
Pan, An ;
Yang, Xiaoming .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (01) :35-45
[4]   The proximal origin of SARS-CoV-2 [J].
Andersen, Kristian G. ;
Rambaut, Andrew ;
Lipkin, W. Ian ;
Holmes, Edward C. ;
Garry, Robert F. .
NATURE MEDICINE, 2020, 26 (04) :450-452
[5]  
[Anonymous], 2021, Overview of the National Monitoring Information on Adverse Events of COVID-19 Vaccination
[6]  
[Anonymous], 2020, Top 15 Countries by GDP
[7]  
[Anonymous], 2020, PRESS C JOINT PREVEN
[8]  
[Anonymous], 2021, PRESS C JOINT PREVEN
[9]  
[Anonymous], 2021, En Tunisie, la region de Kairouan est sinistree par la pandemie de Covid-19
[10]  
BAKAR NA., 2020, International Journal of Advanced Engineering Research and Science, V7, P189, DOI [10.22161/ijaers.74.23, DOI 10.22161/IJAERS.74.23, 10.22161/ijaers.74.23%26gt, DOI 10.22161/IJAERS.74.#26GT]